first in human study
Featured
Triastek Succeeds in First In-Human Study of its 3D Printed Medication
Triastek, a Chinese developer of pharmaceuticals produced with additive manufacturing (AM), announced that the company has completed the first in human (FIH) study of T21, a medication for ulcerative colitis…